SCHEMBL24514219

SCHEMBL24514219

Cc1ccc(/N=N/c2ccc(/N=N/c3ccc(S(=O)(=O)O)cc3)cc2S(=O)(=O)O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 1/20 0.57
CYP1A2 P05177 1/20 0.52
CYP2C9 P11712 1/20 0.52
CD40 P25942 1/20 0.52
CD40LG P29965 1/20 0.52
ATIC P31939 1/20 0.50
POLB P06746 1/20 0.50
CYP2D6 P10635 1/20 0.50
PHLPP2 Q6ZVD8 4/20 0.47
ENPP2 Q13822 2/20 0.47
SENP2 Q9HC62 4/20 0.47
SENP3 Q9H4L4 3/20 0.47
SENP1 Q9P0U3 3/20 0.47
SUMO2 P61956 2/20 0.47
SUMO1 P63165 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HIF1A Q16665 1/20 0.47
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469779 0.92 ALDH1A1 (0.58) RPS6KA3CYP1A2CYP2C9CD40CD40LG
SCHEMBL13265421 0.91 ALDH1A1 (0.57) RPS6KA3CYP1A2CYP2C9CD40CD40LG
SCHEMBL15139210 0.88 SENP2 (0.51) RPS6KA3CYP1A2CYP2C9ATICPOLB
SCHEMBL6125347 0.84 SENP2 (0.61) RPS6KA3CYP1A2CYP2C9CD40CD40LG
SCHEMBL13861833 0.84 POLB (0.68) RPS6KA3CYP1A2CYP2C9POLBCYP2D6
SCHEMBL9612273 0.84 POLB (0.68) RPS6KA3CYP1A2CYP2C9POLBCYP2D6
SCHEMBL19882703 0.83 SENP2 (0.67) RPS6KA3CD40CD40LGATICPOLB
SCHEMBL19235027 0.83 SENP2 (0.57) RPS6KA3CYP1A2CYP2C9ATICPOLB
SCHEMBL19882705 0.83 SENP2 (0.67) RPS6KA3CD40CD40LGATICPOLB
SCHEMBL18218234 0.83 CD40 (0.44) RPS6KA3CYP1A2CYP2C9CD40CD40LG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220184104-A1 SILANOL BASED THERAPEUTIC PAYLOADS BLINKBIO INC (US) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220184104-A1 SILANOL BASED THERAPEUTIC PAYLOADS CD47, CD4, BST2 RPS6KA3 3206/4885CYP1A2 3088/4885CYP2C9 4597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.